ET
COLL icon

Entropy Technologies’s Collegium Pharmaceutical COLL Stock Holding History

Entropy Technologies’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$228K Buy
+6,310
New +$216K 0.01% 851

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Entropy Technologies's COLL Position: Q2 2026 in Review

Entropy Technologies opened a new position in Collegium Pharmaceutical (COLL) in Q2 2026: 6,310 shares worth $228K. The stake represents 0.01% of the portfolio and ranks #851 among its holdings.

279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Entropy Technologies held 6,310 shares of Collegium Pharmaceutical worth $228K as of Q2 2026.
  • Collegium Pharmaceutical was a new Entropy Technologies position in Q2 2026.
  • Collegium Pharmaceutical made up 0.01% of Entropy Technologies's portfolio in Q2 2026, its #851 holding.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.